Close

Prof David Heymann

Prof of Infectious Disease Epidemiology

United Kingdom

David Heymann holds a BA in general science from Penn State University, an M.D from Wake Forest School of Medicine, and a DTM&H from London School of Hygiene and Tropical Medicine (LSHTM). He is currently Professor of Infectious Disease Epidemiology at LSHTM and a Distinguished Fellow at the Centre on Universal Health at Chatham House, London. From 2009 to2012 he was chairman of the UK Health Protection Agency, and from 2012 to March 2017 chairman of Public Health England.
For 22 years Heymann was based at the World Health Organization (WHO) in Geneva on secondment from the Centers for Disease Control and Prevention (CDC) during which time he rose from Chief of Research of the Global Programme on AIDS to Founding Director of the Programme on Emerging and other Communicable Diseases. He then was named Executive Director of the Communicable Diseases Cluster, a position from which he headed the global response to SARS, and finally was named Assistant Director for Health Security and the Director General’s Representative for Polio Eradication.
Before joining WHO Heymann was based for 13 years in sub-Saharan Africa on assignment from CDC where he worked Cameroon, Cote d’Ivoire, DRC and Malawi. During this period he participated in the response to the first, second and third outbreaks of Ebola hemorrhagic fever in DRC, investigated human monkeypox outbreaks throughout central and western Africa, and supported ministries of health in field research aimed at better control of malaria, measles, tuberculosis and other infectious diseases. Prior to joining CDC Heymann worked in India for two years as a medical epidemiologist in the WHO smallpox eradication programme.
Heymann is an elected fellow of the Institute of Medicine of the National Academies (US) and the Academy of Medical Sciences (UK), and has received seven different public health awards, including the Heinz Award on the Human Condition, that have provided funding for the establishment of an on-going mentorship programme at the International Association of Public Health Institutes (IANPHI).
Heymann has published over 275 peer reviewed articles, commentaries and book chapters, and is the editor of the Control of Communicable Diseases Manual, a major global reference for public health and health protection. In 2009 he was appointed an honorary Commander of the Most Excellent Order of the British Empire (CBE) for service to global public health.

Affiliations

Department of Infectious Disease Epidemiology and International Health
Faculty of Epidemiology and Population Health

Centres

Vaccine Centre
Antimicrobial Resistance Centre

Selected Publications

The 2023 – 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the World
Cevik, M; Tomori, O; Mbala, P; Scagliarini, A; Petersen, E; Low, N; HEYMANN, D; Shan Lee, S; Blumberg, L;
2024
IJID Regions
The 2023 - 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the World.
Cevik, M; Tomori, O; Mbala, P; Scagliarini, A; Petersen, E; Low, N; HEYMANN, D; Shan Lee, S; Blumberg, L;
2024
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
McCloskey, B; Saito, T; Shimada, S; Ikenoue, C; Endericks, T; MULLEN, L; Mota, P; Kumar, CK; Laxminarayan, R; Budgett, R; HEYMANN, D; Zumla, A;
2024
Lancet (London, England)
Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022
Barnes, MV C; Mandla, A; Smith, E; Maskuniitty, M; Openshaw, PJ M; Abo, Y-N; Ascough, S; Ashwin, H; Avirutnan, P; Catchpole, AP; Chi, PC; Chiu, C; Darton, TC; Driciru, E; Dula, D; Ferreira, DM; Fraser, A; Garrett, P; Gbesemete, D; Gordon, S; HEYMANN, DL; Houlder, E; Jamrozik, E; Kapulu, M; Kessy, E; ... Welch, O.
2023
Immunotherapy Advances
Moving cholera vaccines ahead of the epidemic curve.
Memish, ZA; Blumberg, L; Al-Maani, AS; Baru, R; Dube, E; Gao, GF; Jernigan, DB; Leo, Y-S; Peiris, JS M; Masud, JH B; McVernon, J; Nonvignon, J; Ogunsola, FT; Reese, H; Safdar, RM; Ungchusak, K; Wieler, LH; HEYMANN, D;
2023
Lancet (London, England)
International and global health
HEYMANN, D; Rao, M; Inamdar, L; Hurwitz, M; Sim, F; Wright, J;
2023
Working in Public Health
Lancet Commission on synergies between universal health coverage, health security, and health promotion.
Agyepong, I; SPICER, N; Ooms, G; Jahn, A; Bärnighausen, T; Beiersmann, C; Brown Amoakoh, H; Fink, G; Guo, Y; Hennig, L; Kifle Habtemariam, M; Kouyaté, BA; Loewenson, R; Micah, A; Moon, S; Moshabela, M; Myhre, SL; Ottersen, T; Patcharanarumol, W; Sarker, M; Sen, G; Shiozaki, Y; Songane, F; Sridhar, D; Ssengooba, F; ... HEYMANN, D.
2023
Lancet (London, England)
Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world.
ADETIFA, I; Muyembe, J-J; Bausch, DG; HEYMANN, DL;
2023
Lancet (London, England)
Cholera vaccine and mass gatherings: protecting the crowds.
Farahat, RA; Khan, SH; Benson, F; HEYMANN, DL; Memish, ZA;
2023
Journal of travel medicine
See more information